Legal Representation
Attorney
Jeremy P. Oczek
USPTO Deadlines
Application History
23 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Mar 1, 2021 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
Feb 26, 2021 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
Aug 14, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Aug 14, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Aug 14, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Nov 6, 2019 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
Oct 16, 2019 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
Mar 28, 2019 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
Mar 5, 2019 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
Feb 2, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
Jul 5, 2018 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
Jul 5, 2018 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
Jul 5, 2018 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
Jun 12, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jun 12, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jun 12, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 7, 2018 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
Dec 14, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Dec 14, 2017 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Dec 14, 2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Dec 7, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Sep 9, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Sep 5, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Providing molecular genetics and genomics testing and reporting services in the field of biomarkers for the susceptibility, risk, diagnosis, prognosis, treatment or management of cancer and other diseases
First Use Anywhere:
Jun 15, 2017
First Use in Commerce:
Jun 15, 2017
Additional Information
Pseudo Mark
IMMUNE REPORT CARD
Classification
International Classes
044